Review
doi: 10.1016/1380-2933(95)00018-6.
CD59: its role in complement regulation and potential for therapeutic use
Affiliations
- PMID: 9373344
- DOI: 10.1016/1380-2933(95)00018-6
Item in Clipboard
Review
CD59: its role in complement regulation and potential for therapeutic use
Immunotechnology.
1995 Dec.
Abstract
CD59 regulates complement activation cascade at the final step, inhibiting formation of membrane attack complex (MAC). This protein, being anchored to the cell membrane via glycosyl phosphatidyl inositol (GPI), is expressed ubiquitously on cells which are in contact with body fluids containing components. Recently, MAC formation has been reported to play an important role in pathogenesis of inflammatory diseases such as ischemia or autoimmune diseases. In this review, we describe the structure and biological activities of CD59, the pathogenic role of MAC formation, and discuss application of soluble molecules of CD59 for therapeutic use.
Similar articles
-
Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review).Int J Oncol. 1998 Aug;13(2):305-18. doi: 10.3892/ijo.13.2.305. Int J Oncol. 1998. PMID: 9664126 Review.
-
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration.J Immunol. 2007 Feb 1;178(3):1783-90. doi: 10.4049/jimmunol.178.3.1783. J Immunol. 2007. PMID: 17237428
-
The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.Am J Pathol. 2011 Dec;179(6):2876-84. doi: 10.1016/j.ajpath.2011.08.040. Epub 2011 Oct 19. Am J Pathol. 2011. PMID: 22019898 Free PMC article.
-
Membrane defence against complement lysis: the structure and biological properties of CD59.Immunol Res. 1993;12(3):258-75. doi: 10.1007/BF02918257. Immunol Res. 1993. PMID: 7507156 Review.
-
The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats.Arthritis Rheum. 1997 Mar;40(3):527-33. doi: 10.1002/art.1780400319. Arthritis Rheum. 1997. PMID: 9082941
Cited by
-
Targeting of functional antibody-CD59 fusion proteins to a cell surface.J Clin Invest. 1999 Jan;103(1):55-61. doi: 10.1172/JCI4607. J Clin Invest. 1999. PMID: 9884334 Free PMC article.
-
Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.Mol Cell Biol. 2008 Aug;28(15):4896-914. doi: 10.1128/MCB.01775-07. Epub 2008 May 27. Mol Cell Biol. 2008. PMID: 18505826 Free PMC article.
-
EGFR modulates complement activation in head and neck squamous cell carcinoma.BMC Cancer. 2020 Feb 13;20(1):121. doi: 10.1186/s12885-020-6615-z. BMC Cancer. 2020. PMID: 32054454 Free PMC article.
-
Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology.Int J Mol Sci. 2024 Nov 28;25(23):12823. doi: 10.3390/ijms252312823. Int J Mol Sci. 2024. PMID: 39684535 Free PMC article. Review.
-
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer.J Clin Invest. 2024 Oct 22;134(24):e180282. doi: 10.1172/JCI180282. J Clin Invest. 2024. PMID: 39436703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous